Latest Content

My smile today is one of compassion. It’s a smile that welcomes the stranger I meet. It radiates joy and presence.

New EGFR-targeting combos may improve response rates and durability for patients with head and neck cancer.

Breast cancer survivor Dr. Sheri Prentiss discusses shifting oncology care from a "wait and see" approach to early lymphedema intervention and advocacy.

Experts highlight the need for tailored care strategies to address fertility, financial strain and survivorship challenges in younger adults with cancer.

Dr. Alexander Meves explains how the Merlin CP-GEP test uses molecular data to help melanoma patients safely avoid unnecessary lymph node surgeries.

A tongue cancer survivor and her oncologist discuss lasting side effects, daily management, self-advocacy and emerging treatment approaches.

Pediatric Cancer Research Foundation CEO Danielle Fragalla discusses the biological differences in pediatric cancer and the need for treatments designed for developing bodies.

Gotistobart reduced risk of death by 54% and doubled 12-month survival vs chemotherapy in advanced squamous NSCLC after prior treatment.

A newly approved all-oral combination for CLL offers patients a fixed-duration option, reducing clinic visits and expanding personalized care.

Libtayo improved survival and safety outcomes vs chemotherapy in advanced NSCLC, with 23% of patients alive at six years in the EMPOWER-Lung 1 trial.

Dr. Reshma Jagsi discusses optimizing breast cancer care by safely de-escalating surgery and radiation using patient-centered communication

Once the reality set in that my sister was cancer-free and in remission, I realized I was unprepared for what life would look like after cancer.

Physician Dr. Sheri Prentiss advocates for baseline measurements and proactive surveillance to detect and treat breast cancer-related lymphedema early.